Literature DB >> 16672557

Oral EBV and KSHV infection in HIV.

J Webster-Cyriaque1, K Duus, C Cooper, M Duncan.   

Abstract

The gamma herpesviruses, Kaposi's-sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV), are tightly associated with the development of AIDS-associated oral disease and malignancy during immune suppression. The objective of this investigation was to characterize oral infection and pathogenesis in healthy and immune-suppressed individuals. To characterize oral EBV and KSHV infection, we examined throat washings and oral epithelial cells from HIV-positive and HIV-negative individuals. Quantitative/real-time polymerase-chain-reaction (PCR) assays, transmission electronmicroscopy, immunostaining, and sequence analysis were used to identify viral infection. Virus was isolated from throat-wash samples and was used to infect epithelial and lymphoid cell lines. We detected EBV and KSHV in the oral cavity in healthy and immune-suppressed individuals. Viral strain analysis of KSHV K1 in multiple clones from the oral cavities of healthy persons and immunosuppressed patients detected several strains previously detected in KS lesions, with minor strain variation within individuals. Immunoelectron microscopy for multiple viral antigens detected consistent expression of viral proteins and oral epithelial specimens. In oral epithelial cells infected with wild-type KSHV in vitro, the K8.1 glycoprotein associated with lytic KSHV infection was detected in both primary and telomerase immortalized oral epithelial cultures by 24 hours post-infection. Virions were detected, subsequent to infection, by scanning electron microscopy. Oral epithelial cells were also infected in vitro with wild-type EBV originating from throat washes. Analysis of these data suggests that, like EBV, KSHV infection is present in the oropharynx of healthy individuals, is transmissible in vitro, and may be transmitted by saliva.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16672557     DOI: 10.1177/154407370601900118

Source DB:  PubMed          Journal:  Adv Dent Res        ISSN: 0895-9374


  14 in total

1.  Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells.

Authors:  Jinjong Myoung; Don Ganem
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

2.  Short-chain fatty acids from periodontal pathogens suppress histone deacetylases, EZH2, and SUV39H1 to promote Kaposi's sarcoma-associated herpesvirus replication.

Authors:  Xiaolan Yu; Abdel-Malek Shahir; Jingfeng Sha; Zhimin Feng; Betty Eapen; Stanley Nithianantham; Biswajit Das; Jonathan Karn; Aaron Weinberg; Nabil F Bissada; Fengchun Ye
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

3.  Viral infections associated with oral cancers and diseases in the context of HIV: a workshop report.

Authors:  D J Speicher; V Ramirez-Amador; D P Dittmer; J Webster-Cyriaque; M T Goodman; A-B Moscicki
Journal:  Oral Dis       Date:  2016-04       Impact factor: 3.511

4.  Macaque homologs of Kaposi's sarcoma-associated herpesvirus (KSHV) infect germinal center lymphoid cells, epithelial cells in skin and gastrointestinal tract and gonadal germ cells in naturally infected macaques.

Authors:  Helle Bielefeldt-Ohmann; A Gregory Bruce; Kellie Howard; Minako Ikoma; Margaret E Thouless; Timothy M Rose
Journal:  Virology       Date:  2018-04-22       Impact factor: 3.616

5.  Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.

Authors:  Jessica A Kahn; Bret J Rudy; Jiahong Xu; Bill Kapogiannis; Elizabeth Secord; Maura Gillison
Journal:  J Med Virol       Date:  2016-05-09       Impact factor: 2.327

Review 6.  Reflections on the interpretation of heterogeneity and strain differences based on very limited PCR sequence data from Kaposi's sarcoma-associated herpesvirus genomes.

Authors:  Jian-Chao Zong; Ravit Arav-Boger; Donald J Alcendor; Gary S Hayward
Journal:  J Clin Virol       Date:  2007-08-14       Impact factor: 3.168

7.  Oncogenic human herpesvirus hijacks proline metabolism for tumorigenesis.

Authors:  Un Yung Choi; Jae Jin Lee; Angela Park; Wei Zhu; Hye-Ra Lee; Youn Jung Choi; Ji-Seung Yoo; Claire Yu; Pinghui Feng; Shou-Jiang Gao; Shaochen Chen; Hyungjin Eoh; Jae U Jung
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-25       Impact factor: 11.205

8.  Utilising proteomic approaches to understand oncogenic human herpesviruses (Review).

Authors:  Christopher B Owen; David J Hughes; Belinda Baquero-Perez; Anja Berndt; Sophie Schumann; Brian R Jackson; Adrian Whitehouse
Journal:  Mol Clin Oncol       Date:  2014-07-09

Review 9.  Kaposi's sarcoma-associated herpesvirus ORF57 protein: exploiting all stages of viral mRNA processing.

Authors:  Sophie Schumann; Brian R Jackson; Belinda Baquero-Perez; Adrian Whitehouse
Journal:  Viruses       Date:  2013-07-26       Impact factor: 5.048

10.  Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune Activation.

Authors:  Pushpa Pandiyan; Souheil-Antoine Younes; Susan Pereira Ribeiro; Aarthi Talla; David McDonald; Natarajan Bhaskaran; Alan D Levine; Aaron Weinberg; Rafick P Sekaly
Journal:  Front Immunol       Date:  2016-06-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.